Berkan Karabuga

12PUBLICATIONS

121CO-AUTHORS

Molecular targetsBiomechanicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 25, 2026

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|Jun 23, 2026

From the stands to survival fandom, a psychosocial force in the fight against cancer.

|May 27, 2026

Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.

|May 04, 2026

Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study.

|Mar 28, 2026

Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

|Mar 26, 2026

Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic.

Berkan Karabuğa, Hatice Gülgün Fırat, Fatih Tay

Pageof 2

Frequent Collaborators

Elif Sahin

Ali Kalem

Öztürk Ateş

Mustafa Seyyar

Taha Koray Sahin

Nadiye Sever

Ozkan Alan

Abdulsamet Erden

Ibrahim Vedat Bayoğlu

2 joint publications

Ilkay Tugba Unek

Frequent Collaborators

Elif Sahin

Ali Kalem

Öztürk Ateş

Mustafa Seyyar